ERAS vs EWTX Stock Comparison

EWTX currently leads ERAS in this stock comparison, with AIQ scores of 72 vs 61. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 11 points
ERAS
Healthcare
vs
EWTX
Healthcare
ERAS
Erasca, Inc.
Price
$15.66
Day move
-0.76%
AIQ Score
61/100
Best edge
Balanced
Sector
Healthcare
EWTX
Edgewise Therapeutics, Inc.
Leads
Price
$45.93
Day move
+0.24%
AIQ Score
72/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between ERAS and EWTX?

EWTX leads the current stock comparison as Edgewise Therapeutics, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Erasca, Inc. vs Edgewise Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 59/66 fields· Moderate confidence
AIQ VerdictFragileAIQ Comparison Conviction 6/10

EWTX leads

EWTX leads by 11 AIQ points, primarily on Risk Resilience and Momentum, but the lead has narrowed from 26 points over 30 sessions.

Fragile: 4 of 4 evidence groups support EWTX, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 4 of 4Comparison trend: Weakening
ERAS

Erasca, Inc.

AIQ Score
61/100
AIQ Edge Score
10/10
EWTX

Edgewise Therapeutics, Inc.

Leads
AIQ Score
72/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors EWTX over ERAS, 72 versus 61 as of Nov 15, 2026. EWTX's advantage is driven primarily by stronger risk resilience and momentum. EWTX also shows the stronger technical structure relative to its 50-day moving average. 4 of 4 covered evidence groups favor EWTX today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. EWTX lead: Weakening — the AIQ differential moved from 26 to 11 points over 30 sessions.

Compare Erasca, Inc. and Edgewise Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ERAS
-20.7%
EWTX
+120.2%

Price return comparison

Growth of $10,000, price only

ERAS $7,929 · EWTX $22,018

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ERAS and EWTX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ERAS advantage
0
EWTX advantage
  • Risk Resilience39 vs 57
    EWTX +18
  • Momentum67 vs 82
    EWTX +15
  • Quality65 vs 68
    Even

4 of 4 evidence groups favor EWTX. EWTX’s edge is concentrated in risk resilience and momentum.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ERAS+9 AIQ

Largest factor move: Quality +21

New signals

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.70x)
EWTX+3 AIQ

Largest factor move: Momentum +7

No signal started or stopped since the prior session; its 7 active signals are unchanged.

EWTX's lead narrowed by 6 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — ERAS and EWTX both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

EWTX

EWTX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

EWTX

EWTX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

EWTX

EWTX on the Momentum factor, by 15 points.

Lower downside

EWTX

EWTX on Risk Resilience, by 18 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureERASEWTXNote
Implied upside to target—+54.6%Level
Target dispersion—+39.4%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering913Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 4 covered evidence groups favor EWTX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEWTX61 vs 72
FundamentalsEWTXrevenue growth 0% vs 0%; EPS growth -7.1% vs 21.2%; TTM ROE -5.6% vs 71.4%; gross margin 0% vs 0%; operating margin 0% vs 0%
ValuationNot coveredNot covered
TechnicalsEWTXPrice vs 50-day 4.7% vs 11.1%; vs 200-day 2.6% vs 24.1%
Risk ResilienceEWTXRisk Resilience 39 vs 57
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ERAS and EWTX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 11 points.
  • 4 of 4 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has swung materially session to session. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EWTX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

EWTX lead: Weakening — the AIQ differential moved from 26 to 11 points over 30 sessions.

May 27ERAS leads above the line · EWTX leads belowNov 13
Today
EWTX +11
61 vs 72
7 sessions ago
EWTX +16
51 vs 67
30 sessions ago
EWTX +26
41 vs 67
90 sessions ago
EWTX +15
59 vs 74

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ERASConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only ERAS

  • Death Cross Active — bearish, trend, long horizon (2.00%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.70x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
EWTXConflicted

4 bullish / 1 bearish / 2 neutral, conflicted

Only EWTX

  • Golden Cross Active — bullish, trend, long horizon (11.68%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.67x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish.

EWTX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ERASDivergence

Price is down while the AIQ Score moved up 9 points over the same session — price and model disagree (price -0.76%, AIQ +9 points).

EWTXConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.24%, AIQ +3 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ERAS closes the Risk Resilience gap — currently 18 points behind, the largest single contributor to EWTX's edge.
  2. 2ERAS's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3EWTX's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 15 points over 30 sessions, and a further 11-point move would eliminate EWTX's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

EWTX leads on balance
MetricERASEWTX
Revenue growth (YoY)0%0%
EPS growth (YoY)-7.1%21.2%
Gross margin0%0%
Operating margin0%0%
Return on equity (TTM)-5.6%71.4%
Debt to equity0.050

Performance

ERAS leads 4 of 6 windows
MetricERASEWTX
1 week (5 sessions)8.7%2%
1 month (20 sessions)17%23.5%
3 months (63 sessions)-14.3%4.3%
6 months (126 sessions)53.1%38.8%
Year to date321%85.1%
1 year (252 sessions)490.9%117%

Technicals

EWTX has the stronger structure
MetricERASEWTX
RSI (14)53.861.8
ADX (14)11.623.1
Price vs 50-day4.7%11.1%
Price vs 200-day2.6%24.1%
Volatility (1M, annualized)81.1%73.1%

Risk

EWTX is the more resilient
MetricERASEWTX
Beta1.621.1
Sharpe ratio2.291.41
Sortino ratio3.652.62
Max drawdown-59.5%-25%
Current drawdown-30.3%-5.8%
Annualized volatility102.7%73.2%
Value at risk (95%)-6.6%-5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ERAS or EWTX?

On the Algovestiq AIQ Score, EWTX is the stronger of the two as of Nov 15, 2026, scoring 72 against ERAS's 61. The edge comes from risk resilience and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ERAS or EWTX the better buy right now?

EWTX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 4 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.

Why does the AIQ Score favor EWTX over ERAS?

The composite weights Quality, Value, Momentum and Risk Resilience. EWTX leads Risk Resilience by 18 points; EWTX leads Momentum by 15 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ERAS or EWTX?

Analyst price targets imply not covered upside for ERAS and +54.6% for EWTX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ERAS or EWTX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ERAS or EWTX?

EWTX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ERAS or EWTX?

EWTX on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ERAS or EWTX?

EWTX is the more resilient of the two, so the other name carries the higher downside risk. EWTX on Risk Resilience, by 18 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ERAS more profitable than EWTX?

EWTX leads on the comparable margin measures — gross margin 0% vs 0%; operating margin 0% vs 0%; ttm roe -5.6% vs 71.4%.

Is EWTX's lead over ERAS getting stronger or weaker?

EWTX lead: Weakening — the AIQ differential moved from 26 to 11 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ERAS vs EWTX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ERAS closes the Risk Resilience gap — currently 18 points behind, the largest single contributor to EWTX's edge; ERAS's Death Cross Active resolves — a bearish trend rule currently active against it; EWTX's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 15 points over 30 sessions, and a further 11-point move would eliminate EWTX's advantage entirely.

What do the current signals say about ERAS and EWTX?

ERAS: 2 bullish / 2 bearish / 2 neutral, conflicted. EWTX: 4 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ERAS is Death Cross Active (bearish, long horizon). On EWTX it is Golden Cross Active (bullish, long horizon).

Compare ERAS and EWTX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.